Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Axsome Therapeutics, Inc. (AXSM) had Debt to Equity Ratio of 2.36 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$218.38M |
|
$-51.31M |
|
$13.56M |
|
$204.81M |
|
$268.02M |
|
$-49.65M |
|
$-1.54M |
|
$-51.19M |
|
$-51.19M |
|
$-51.31M |
|
$-51.31M |
|
$-51.31M |
|
$-51.31M |
|
$-49.65M |
|
$-46.59M |
|
51.80M |
|
51.80M |
|
$-0.99 |
|
$-0.99 |
|
| Balance Sheet Financials | |
$656.57M |
|
$0.87M |
|
$104.88M |
|
$761.45M |
|
$460.45M |
|
$126.99M |
|
$217.70M |
|
$678.14M |
|
$83.30M |
|
$33.90M |
|
$83.30M |
|
52.30M |
|
| Cash Flow Statement Financials | |
$-53.65M |
|
$-0.57M |
|
$51.14M |
|
$322.93M |
|
$319.85M |
|
$-3.08M |
|
$50.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
0.60 |
|
|
Debt to Equity Ratio |
2.36 |
93.79% |
|
-22.73% |
|
-22.73% |
|
-- |
|
-23.44% |
|
-23.50% |
|
$-54.22M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.36 |
|
0.79 |
|
114.35 |
|
-61.60% |
|
-151.35% |
|
-6.74% |
|
-24.40% |
|
$1.59 |
|
$-1.05 |
|
$-1.04 |
|